Corrigendum to: Implications of time-series gene expression profiles of replicative senescence (Aging Cell, (2013), 12, 4, (622-634), 10.1111/acel.12087);Implications of time-series gene expression profiles of replicative senescence

Aging Cell

Volumn 12, Issue 4, 2013, Pages 622-634

  Kim, You Mi ^a   Byun, Hae Ok ^a   Jee, Byul A ^a   Cho, Hyunwoo ^a   Seo, Yong Hak ^a   Kim, You Sun ^a   Park, Min Hi ^b   Chung, Hae Young ^b   Woo, Hyun Goo ^a   Yoon, Gyesoon ^a  

^a Ajou University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Gene expression; Human diploid fibroblasts; Replicative senescence; Senescence associated secretory phenotype

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; INTERLEUKIN DERIVATIVE; MACROPHAGE ELASTASE; TRANSCRIPTOME;

ANIMAL TISSUE; ARTICLE; CELL AGING; CELL GROWTH; CELL SIZE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SENESCENCE; TIME SERIES ANALYSIS; ANIMAL; CELL CYCLE; CELL DEATH; CYTOLOGY; DIPLOIDY; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

RATTUS;

ANIMALS; BETA-GALACTOSIDASE; CELL AGING; CELL CYCLE; CELL DEATH; CELL SIZE; DIPLOIDY; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; MATRIX METALLOPROTEINASE 12; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS; TRANSCRIPTOME;

EID: 84880506559     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.13165     Document Type: Erratum

References (45)

1. Ahmed N., Ahmad T., Hussain S. J., Javed M. (2010) Frequency of metabolic syndrome in patients with type-2 diabetes. J. Ayub Med. Coll. Abbottabad 22, 139-142.
2. Benz C. C. (2008) Impact of aging on the biology of breast cancer. Crit. Rev. Oncol. Hematol. 66, 65-74.
3. Brookes S., Rowe J., Gutierrez Del Arroyo A., Bond J., Peters G. (2004) Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Exp. Cell Res. 298, 549-559.
4. Burton D. G. (2009) Cellular senescence, ageing and disease. Age (Dordr.) 31, 1-9.
5. Byun H. O., Kim H. Y., Lim J. J., Seo Y. H., Yoon G. (2008) Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J. Cell. Biochem. 104, 1747-1759.
6. Campisi J., Andersen J. K., Kapahi P., Melov S. (2011) Cellular senescence: a link between cancer and age-related degenerative disease? Semin. Cancer Biol. 21, 354-359.
7. Carnes B. A., Staats D. O., Sonntag W. E. (2008) Does senescence give rise to disease? Mech. Ageing Dev. 129, 693-699.
8. Castro P., Giri D., Lamb D., Ittmann M. (2003) Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55, 30-38.
9. Cristofalo V. J., Lorenzini A., Allen R. G., Torres C., Tresini M. (2004) Replicative senescence: a critical review. Mech. Ageing Dev. 125, 827-848.
10. Erusalimsky J. D., Kurz D. J. (2005) Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp. Gerontol. 40, 634-642.
11. Fornai F., Schluter O. M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C. L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., Sudhof T. C. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A. 102, 3413-3418.
12. Fossel M. (2002) Cell senescence in human aging and disease. Ann. N. Y. Acad. Sci. 959, 14-23.
13. Freund A., Orjalo A. V., Desprez P. Y., Campisi J. (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16, 238-246.
14. Guengerich F. P., Johnson W. W., Ueng Y. F., Yamazaki H., Shimada T. (1996) Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ. Health Perspect. 104(Suppl 3), 557-562.
15. Harley C. B., Villeponteau B. (1995) Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev. 5, 249-255.
16. Hayflick L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
17. Herbig U., Jobling W. A., Chen B. P., Chen D. J., Sedivy J. M. (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501-513.
18. Herron G. S., Werb Z., Dwyer K., Banda M. J. (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261, 2810-2813.
19. Hwang E. S., Yoon G., Kang H. T. (2009) A comparative analysis of the cell biology of senescence and aging. Cell. Mol. Life Sci. 66, 2503-2524.
20. Itahana K., Zou Y., Itahana Y., Martinez J. L., Beausejour C., Jacobs J. J., Van Lohuizen M., Band V., Campisi J., Dimri G. P. (2003) Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23, 389-401.
21. Jasperson K. W., Tuohy T. M., Neklason D. W., Burt R. W. (2010) Hereditary and familial colon cancer. Gastroenterology 138, 2044-2058.
22. Kim H. S., Song M. C., Kwak I. H., Park T. J., Lim I. K. (2003) Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence. J. Biol. Chem. 278, 37497-37510.
23. Kim Y. M., Shin H. T., Seo Y. H., Byun H. O., Yoon S. H., Lee I. K., Hyun D. H., Chung H. Y., Yoon G. (2010) Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence. J. Biol. Chem. 285, 29069-29077.
24. Kitada T., Seki S., Kawakita N., Kuroki T., Monna T. (1995) Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun. 211, 33-39.
25. Levy M. Z., Allsopp R. C., Futcher A. B., Greider C. W., Harley C. B. (1992) Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951-960.
26. Ling C., Groop L. (2009) Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58, 2718-2725.
27. Liu F., Wu S., Ren H., Gu J. (2011) Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell Biol. 13, 254-262.
28. Morin G. B. (1997) Telomere control of replicative lifespan. Exp. Gerontol. 32, 375-382.
29. Munter L. M., Botev A., Richter L., Hildebrand P. W., Althoff V., Weise C., Kaden D., Multhaup G. (2010) Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J. Biol. Chem. 285, 21636-21643.
30. Neill D. (2012) Should Alzheimer's disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence. Ageing Res. Rev. 11, 104-122.
31. Orjalo A. V., Bhaumik D., Gengler B. K., Scott G. K., Campisi J. (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U. S. A. 106, 17031-17036.
32. Porta E. A., Sablan H. M., Joun N. S., Chee G. (1982) Effects of the type of dietary fat at two levels of vitamin E in Wistar male rats during development and aging. IV. Biochemical and morphometric parameters of the heart. Mech. Ageing Dev. 18, 159-199.
33. Rocca W. A., Petersen R. C., Knopman D. S., Hebert L. E., Evans D. A., Hall K. S., Gao S., Unverzagt F. W., Langa K. M., Larson E. B., White L. R. (2011) Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 7, 80-93.
34. Rodier F., Campisi J. (2011) Four faces of cellular senescence. J. Cell Biol. 192, 547-556.
35. Schmucker D. L., Sachs H. (2002) Quantifying dense bodies and lipofuscin during aging: a morphologist's perspective. Arch. Gerontol. Geriatr. 34, 249-261.
36. Seo Y. H., Jung H. J., Shin H. T., Kim Y. M., Yim H., Chung H. Y., Lim I. K., Yoon G. (2008) Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation. Aging Cell 7, 894-907.
37. Shay J. W., Wright W. E., Werbin H. (1991) Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072, 1-7.
38. Somel M., Guo S., Fu N., Yan Z., Hu H. Y., Xu Y., Yuan Y., Ning Z., Hu Y., Menzel C., Hu H., Lachmann M., Zeng R., Chen W., Khaitovich P. (2010) MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res. 20, 1207-1218.
39. Sone H., Kagawa Y. (2005) Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48, 58-67.
40. Terman A., Dalen H., Eaton J. W., Neuzil J., Brunk U. T. (2003) Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp. Gerontol. 38, 863-876.
41. Tong M., Longato L., de la Monte S. M. (2010) Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocr. Disord. 10, 4.
42. VanSaun M. N., Lee I. K., Washington M. K., Matrisian L., Gorden D. L. (2009) High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am. J. Pathol. 175, 355-364.
43. Vasile E., Tomita Y., Brown L. F., Kocher O., Dvorak H. F. (2001) Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15, 458-466.
44. Yoon Y. S., Yoon D. S., Lim I. K., Yoon S. H., Chung H. Y., Rojo M., Malka F., Jou M. J., Martinou J. C., Yoon G. (2006) Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J. Cell. Physiol. 209, 468-480.
45. Youdim M. B., Riederer P. (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. Neural Transm. Suppl. 40, 57-67.